Key takeways
SSRIs affect serotonin in the brain, disrupting body temperature control and causing excessive sweating or night sweats.
Antidepressant sweating is often related to drug dose and is reported more frequently with medications like Zoloft and Paxil.
Managing side effects like sweating requires consulting a doctor to safely taper doses gradually without triggering withdrawal.
Why SSRIs Can Make You Sweat
SSRI sweating, also called antidepressant-induced hyperhidrosis, is a common side effect in which drugs like Zoloft (sertraline), Lexapro (escitalopram) or Prozac (fluoxetine) cause heavy daytime or night sweats. The exact cause is not settled, but it is thought to involve the drug's effects on the brain's temperature control system.
Consider someone who has been on Zoloft for several years and starts waking up drenched in the middle of the night, changing their shirt or the sheets before they can get back to sleep. Nothing is wrong with their fitness or their general health. Heavy sweating is a known side effect of SSRIs, yet it often goes unmentioned in clinical visits, and people end up managing it on their own.
What Happens in the Body When SSRIs Cause Sweating
SSRI sweating tends to look different from the sweating you get on a hot day or during exercise. It is often heavy and spread across the chest, back and face, and it can happen in a cool room or while you are resting, not just as sweaty palms.
The mechanism has not been proven. One leading explanation starts with the hypothalamus, a region of the brain that works like an internal thermostat. SSRIs change how serotonin signaling works in the brain and the body, and one hypothesis is that this change can interfere with the signals that manage body temperature, so the hypothalamus responds as if the body were overheating. Norepinephrine, another chemical messenger that has a strong influence on the sweat glands, may also play a part. If this explanation is right, it would account for why someone can sweat heavily while sitting quietly in an air-conditioned room.
What is clear is that the sweating is a physical effect of the medication. Many people hesitate to mention it to their clinician because it feels embarrassing, or they assume it is just a change in their body. It is worth raising.
Do Antidepressants Cause Night Sweats?
Yes. Sweating during sleep is one of the patterns people taking SSRIs describe most often. Heavy night sweats can break up your sleep and leave you tired the next day. Zoloft, Lexapro, Prozac and Paxil (paroxetine) are all associated with night sweats, and for some people the sweating is heavy enough that they sleep on towels or change pajamas more than once a night.
A cooler bedroom, a fan or moisture-wicking sheets can make nights more comfortable. These measures do not change the effect of the drug itself, though. Dealing with the sweating over the long term usually means a candid conversation with your clinician about your treatment plan, not just new bedding.
Do All Antidepressants Make You Sweat?
Sweating can happen with any SSRI, but it does not affect everyone who takes one. Two people on the same drug and the same dose can have very different experiences: one may sweat heavily, the other not at all. A drug that causes heavy sweating for one person may cause little for someone else.
Among people already taking SSRIs, the sweating often seems to be more noticeable at higher doses. Brain-imaging research shows that the share of serotonin transporters an SSRI occupies rises with dose, steeply at first and then leveling off (Meyer et al., 2004). If the sweating becomes hard to live with, your clinician can review your current dose with you and discuss whether a change makes sense.
Timing and Patterns of SSRI Sweating
When SSRI sweating appears varies a lot from person to person. Some people notice it early in treatment. For others it shows up after a dose change or years into treatment. It can happen in the middle of the day without any exertion, or it can show up only as severe night sweats.
Even though sweating is a known side effect, your clinician should still rule out other causes, such as menopause, thyroid conditions and infections. This matters most if heavy sweating starts suddenly after years on the same medication without any problems.
How a Clinician May Approach the Sweating
If you want to do something about the sweating, the most important step is to avoid making sudden changes to your medication on your own. Changing a psychiatric medication is a shared decision you make with your clinician.
A clinician may look first at your current dose. Because side effects can be tied to how much drug is active in the body, some people and their clinicians consider a gradual dose reduction to see whether a lower dose eases the sweating. Here the pharmacology matters. PET imaging shows that SSRIs occupy roughly 80% of serotonin transporters at their minimum therapeutic doses, and occupancy rises steeply at low doses and plateaus at higher doses (Meyer et al., 2004). In other words, each milligram has a larger effect at low doses than at high doses.
Because of this curve, the Maudsley Deprescribing Guidelines describe tapering as a repeated cycle: a reduction, a period of watching for withdrawal symptoms, and a next step sized by how well the last one went (Horowitz & Taylor, 2024; Dr. Mark Horowitz is Outro Health's clinical co-founder). The book also notes that peer-led tapering communities have found through years of trial and error that dose reductions of about 10% of the most recent dose, so that each reduction is smaller than the last, are the most helpful in getting people off their medication, and such regimens closely approximate the hyperbolic schedules derived from receptor-occupancy data. The guidelines present this as community experience, not a fixed schedule, and a clinician individualizes it. The aim is for the final step to zero to be no larger, in receptor-occupancy terms, than the steps already tolerated, which often means liquid or compounded formulations near the end.
This kind of gradual reduction may be worth discussing if the sweating is intolerable and you want to explore a lower dose under clinical supervision, or if you feel the side effects now outweigh what the medication gives you. It is not a way to stop abruptly or without a clinician, and it is not a fast fix: safe deprescribing takes time and careful monitoring.
Withdrawal Risks When Changing Your Dose
When the sweating is wearing you down, it can be tempting to skip doses, take the medication every other day or stop altogether. Please don't stop an antidepressant suddenly without clinical support. Stopping abruptly or reducing too quickly can cause withdrawal symptoms that are far more disruptive than the sweating.
If you have thoughts of suicide or self-harm, or you feel you are in crisis, call or text 988 to reach the Suicide and Crisis Lifeline in the US, or call 911 or go to the nearest ER.
Withdrawal is highly individual. Some people have mild symptoms for days or weeks, while many have prolonged symptoms that last months or longer and are often mistaken for relapse. Risk factors for more severe withdrawal include a longer time on the drug, a higher dose, a short half-life, past withdrawal and stopping quickly. A drug's half-life shapes how fast it leaves your body, but the drug clearing your system does not mean the brain's adaptations have reversed, so prolonged withdrawal is still possible as the brain adjusts to the absence of the medication. In 2019, the Royal College of Psychiatrists called for greater recognition that some people experience severe and long-lasting withdrawal symptoms on and after stopping antidepressants, and for evidence-based guidance on gradual withdrawal (Royal College of Psychiatrists, 2019).
Guidelines generally suggest continuing treatment for six to nine months after a first episode, or two years or more for recurrent episodes (see NICE guidance). What looks like a recurrent episode, though, can sometimes be tolerance to the medication or withdrawal from a taper that went too fast. Withdrawal is different from relapse: NICE advises that relapse does not usually happen as soon as someone stops or lowers an antidepressant, and withdrawal can include symptoms that are not typical of depression, such as dizziness or electric-shock sensations (NICE, 2022). Where relapse is a worry, it helps to know that most people recover from depression within a year, including the severe group (Whiteford et al., 2013).
Delayed Onset Withdrawal
Timing alone does not settle whether new symptoms are withdrawal or relapse. Withdrawal symptoms can be delayed for several weeks or even months after a dose reduction or the last dose, which is often called delayed onset withdrawal. It is best known with Prozac (fluoxetine), because its active metabolite, norfluoxetine, stays in the body for weeks. It also happens with shorter-acting SSRIs and SNRIs, possibly because drug levels in the brain take longer to adjust than levels in the blood (Horowitz & Taylor, 2022; Horowitz & Taylor, 2024). That is why late symptoms are so often misread as relapse or a new illness.
This matters for sweating too. If sweating starts or gets worse after a dose reduction, ask your clinician to assess whether it could be withdrawal rather than a side effect. A 2023 review found that longer use, SNRIs and paroxetine, and past withdrawal experience are associated with a higher risk of antidepressant withdrawal (Horowitz et al., 2023). If any new symptoms appear after a dose change, even weeks later, raise withdrawal as a possibility.
"Very small doses can still have big effects on the brain—often 1/10 of the minimum standard dose will have about half the effect of the maximum dose."
Dr. Mark Horowitz, Clinical Co-Founder of Outro Health (Psychology Today, 2025)
Conclusion
SSRI sweating is a real physical effect of the medication. It can break up your sleep, make workdays uncomfortable and wear on you over time. Whether you are changing shirts at the office or waking up soaked at night, tell your clinician. Together you can weigh the side effects against your treatment goals, rule out other causes, and decide whether a carefully managed, hyperbolic taper is a step you want to consider.
Outro Health's Tapering Program
If you and your clinician decide that coming off your medication is right for you, Outro Health's Taper Management Program offers clinician-guided tapering based on the hyperbolic method. A dedicated clinician plans personalized, proportional reductions with you, monitors withdrawal symptoms along the way, and coordinates with compounding pharmacies for the very small doses needed near the end of a taper. If your body needs to slow down, the taper slows down.
Outro Health's tapering program is currently available to patients in more than a dozen states, including California, Florida, New York, Texas and more. If you live in one of them, you can learn whether an evaluation is a good fit for you.
Frequently Asked Questions
How to Stop Night Sweats From Antidepressants?
The most reliable first step is to talk with your clinician about the sweating and your current dose. Because sweating often seems to track dose, a clinician may discuss a slow, gradual reduction in proportional steps rather than stopping (Horowitz & Taylor, 2024). A cooler room, a fan or moisture-wicking sheets can ease the discomfort but do not change the drug's effect. Never stop your medication suddenly without clinical support, because that can trigger severe withdrawal symptoms.
Is SSRI Sweating a Sign Something Else Is Wrong?
Often it is simply a side effect of the medication, but it is worth checking. Heavy sweating can also come from menopause, thyroid problems or an infection, so a clinician should rule these out, especially if the sweating starts suddenly after years on the same dose without any issues. Sweating that begins or gets worse after a dose reduction is another reason to speak up, because your clinician may want to consider withdrawal as well as side effects.
What Are the First Signs of Withdrawal?
Withdrawal can include symptoms that are not typical of depression, such as dizziness or electric-shock sensations (NICE, 2022). Timing and severity vary widely: some people notice symptoms within days of a dose reduction, others weeks or months later, and some have mild symptoms while many have prolonged ones often mistaken for relapse. Because these symptoms can resemble other conditions, dose changes are best monitored by a clinician. Do not stop a medication suddenly without clinical support.
Want to explore safe tapering?
Book an evaluation with an Outro clinician, trained in deprescribing.
The information provided on this page is for educational and informational purposes only and is not intended as medical advice. It should not be used to diagnose, treat, cure, or prevent any medical condition. Always seek the guidance of a qualified healthcare professional with any questions you may have regarding your health, medical condition, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. If you are experiencing a medical emergency, please call 911 (or your local emergency number) immediately.
- Horowitz MA, Framer A, Hengartner MP, Sørensen A, Taylor D (2023). Estimating Risk of Antidepressant Withdrawal from a Review of Published Data. CNS Drugs 37(2):143-157. https://doi.org/10.1007/s40263-022-00960-y
- Horowitz MA, Taylor D (2022). Distinguishing relapse from antidepressant withdrawal: clinical practice and antidepressant discontinuation studies. BJPsych Advances 28(5):297-311. https://doi.org/10.1192/bja.2021.62
- Horowitz MA, Taylor D (2024). The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs. Wiley-Blackwell. https://doi.org/10.1002/9781394291052.mdg005
- Meyer JH, Wilson AA, Sagrati S, Hussey D, Carella A, Potter WZ, Ginovart N, Spencer EP, Cheok A, Houle S (2004). Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. American Journal of Psychiatry 161(5):826-835. https://doi.org/10.1176/appi.ajp.161.5.826
- National Institute for Health and Care Excellence (2022). Depression in adults: treatment and management (NICE guideline NG222). https://www.nice.org.uk/guidance/ng222/chapter/Recommendations
- Royal College of Psychiatrists (2019). Position statement on antidepressants and depression (PS04/19). https://www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/position-statements/ps04_19---antidepressants-and-depression.pdf
- Whiteford HA, Harris MG, McKeon G, Baxter A, Pennell C, Barendregt JJ, Wang J (2013). Estimating remission from untreated major depression: a systematic review and meta-analysis. Psychological Medicine 43(8):1569-1585. https://doi.org/10.1017/S0033291712001717



